| 51 |
8649799 | S phase cell-cycle arrest following DNA damage is independent of the p53/p21(WAF1) signalling pathway. | 1996 Mar 7 |
1 |
| 52 |
8756655 | A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. | 1996 Sep |
2 |
| 53 |
8810317 | Regulation of mutant p53 temperature-sensitive DNA binding. | 1996 Oct 11 |
1 |
| 54 |
8967975 | Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. | 1996 Dec |
2 |
| 55 |
7479838 | The ability to associate with activation domains in vitro is not required for the TATA box-binding protein to support activated transcription in vivo. | 1995 Nov 7 |
1 |
| 56 |
7539102 | Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. | 1995 Jun |
1 |
| 57 |
7624116 | A human temperature-sensitive p53 mutant p53Val-138: modulation of the cell cycle, viability and expression of p53-responsive genes. | 1995 Jul 6 |
2 |
| 58 |
7624134 | Cdk2 kinase phosphorylates serine 315 of human p53 in vitro. | 1995 Jul 6 |
2 |
| 59 |
7657383 | Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples. | 1995 Aug 22 |
1 |
| 60 |
8033090 | Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. | 1994 Jul 15 |
1 |
| 61 |
8152811 | Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1. | 1994 May |
1 |
| 62 |
8389256 | p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. | 1993 May |
1 |
| 63 |
8406999 | Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. | 1993 Oct 21 |
2 |
| 64 |
8502477 | Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. | 1993 Jun |
5 |
| 65 |
1450522 | Preference of human cdc2 kinase for peptide substrate. | 1992 Sep-Oct |
1 |
| 66 |
1466808 | Conformational effects of selected cancer-related amino acid substitutions in the p53 protein. | 1992 Oct |
2 |
| 67 |
2052362 | Association of casein kinase II with immunopurified p53. | 1991 May |
1 |